Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Ramesh K RamanathanHoward S Hochster

Abstract

Pegylated recombinant human hyaluronidase (PEGPH20) degrades hyaluronan (HA) and, in combination with chemotherapy, prolongs survival in preclinical models. The activity of PEGPH20 with modified fluorouracil, leucovorin, irinotecan, and oxaliplatin (mFOLFIRINOX) was evaluated in patients with metastatic pancreatic cancer (mPC). Patients had untreated mPC, a performance status of 0 to 1, and adequate organ function. Tumor HA status was not required for eligibility. After a phase Ib dose-finding study of mFOLFIRINOX plus PEGPH20, the phase II open-label study randomly assigned patients (1:1) to the combination arm or to mFOLFIRINOX alone (n = 138). The primary end point was overall survival (OS). PEGPH20 dosages of 3 µg/kg every 2 weeks were more tolerable than twice-weekly dosages used in the phase I study, so 3 µg/kg every 2 weeks was the phase II dosage. An amendment instituted enoxaparin prophylaxis in the PEGPH20 combination arm as a result of increased thromboembolic (TE) events. The planned interim futility analysis when 35 deaths (of 103 analyzable patients) occurred resulted in an OS hazard ratio (HR) of 2.07 that favored the control arm, and the study was closed to accrual. The treatment-related grade 3 to 4 toxicity wa...Continue Reading

References

Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Oct 28, 2010·Molecular Cancer Therapeutics·Curtis B ThompsonGregory I Frost
May 13, 2011·The New England Journal of Medicine·Thierry ConroyUNKNOWN PRODIGE Intergroup
Oct 18, 2013·The New England Journal of Medicine·Daniel D Von HoffMarkus F Renschler
Feb 20, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Clifford J WhatcottHaiyong Han
Jul 15, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithJames O Armitage
Nov 4, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniel V T CatenacciHedy L Kindler
Jan 28, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil R HingoraniCraig E Devoe
Jun 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Davendra P S SohalDaniel Laheru
Jul 29, 2016·British Journal of Cancer·Muralidharan K ChllammaJennifer J Knox
Sep 28, 2017·British Journal of Cancer·Jeffrey R InfanteRamesh K Ramanathan
Dec 13, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sunil R HingoraniAndrew E Hendifar
Dec 20, 2017·Expert Review of Anticancer Therapy·Anteneh A TesfayePhilip A Philip
Dec 23, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin A Krantz, Eileen M O'Reilly
Dec 31, 2017·Gastroenterology·Claire VenninPaul Timpson
Jan 9, 2018·Chinese Clinical Oncology·Daniel H Ahn, Ramesh K Ramanathan
Apr 5, 2018·Clinical Colorectal Cancer·Pedro Luiz Serrano Usón JuniorDiogo Diniz Gomes Bugano
Apr 11, 2018·Cancer Chemotherapy and Pharmacology·Masato OzakaJunji Furuse

❮ Previous
Next ❯

Citations

Mar 13, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea Wang-Gillam
May 1, 2019·Cancers·Madelaine G van MackelenberghHanneke W M van Laarhoven
Oct 24, 2019·International Journal of Cancer. Journal International Du Cancer·Inna M ChenJulia S Johansen
Dec 4, 2019·The Journal of Clinical Investigation·Won Jin Ho, Elizabeth M Jaffee
Nov 20, 2019·The Oncologist·Suneel D KamathMary Mulcahy
Jul 20, 2020·CA: a Cancer Journal for Clinicians·Aaron J GrossbergCharles R Thomas
Mar 13, 2020·Seminars in Liver Disease·Luca FabrisGregory J Gores
Dec 19, 2019·Nature Reviews. Clinical Oncology·Sarwish RafiqRenier J Brentjens
Apr 20, 2020·Drugs·Ritu Raj Singh, Eileen M O'Reilly
May 13, 2020·Nature Reviews. Gastroenterology & Hepatology·Abdel N HoseinAnirban Maitra
Jul 28, 2020·Cancers·Caspar FranckMarino Venerito
Oct 11, 2019·Therapeutic Advances in Medical Oncology·Aurélien LambertThierry Conroy
Sep 24, 2020·Cancers·Namrata KhuranaKian-Huat Lim
Jul 17, 2020·Future Science OA·Ibrahim Halil Sahin
Oct 5, 2019·Gastroenterology Research and Practice·Caroline Y K FongNaureen Starling
Jul 25, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric Van CutsemUNKNOWN HALO 109-301 Investigators
Dec 31, 2019·Journal of Oncology·Silvia BatistaBruno Costa-Silva
May 14, 2020·Nature Reviews. Clinical Oncology·Won Jin HoLei Zheng
Oct 18, 2020·Cancers·Marc HilmiCindy Neuzillet
May 30, 2020·Physiological Reviews·Giulia Biffi, David A Tuveson
Jun 13, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex B BlairLei Zheng
Mar 30, 2020·Molecular Cancer Therapeutics·Sriram AnbilTayyaba Hasan
Jan 3, 2021·Annals of Surgical Oncology·Flavio G Rocha
Sep 19, 2020·Cancer Cell·Adham S BearMark H O'Hara
Jan 21, 2021·Nature Reviews. Clinical Oncology·Jiajie HouBeicheng Sun
Nov 19, 2019·Trends in Cancer·Emiel A De JaeghereOlivier De Wever
Jan 28, 2021·Expert Opinion on Therapeutic Targets·Corentin LouisCédric Coulouarn
Feb 8, 2021·Cancer Letters·Daniel R PrincipeAjay Rana
Feb 7, 2021·Journal of Clinical Medicine·Andres Garcia-SampedroPilar Acedo
Feb 17, 2021·Nature Reviews. Cancer·Thomas R Cox
Oct 31, 2020·Signal Transduction and Targeted Therapy·Ashenafi Bulle, Kian-Huat Lim
Feb 17, 2021·Deutsche medizinische Wochenschrift·Patrick Wenzel, Guido von Figura
Mar 12, 2021·Cancer Biology & Therapy·Christopher W SchultzFlemming Forsberg
Mar 7, 2021·Seminars in Oncology·Aurélien LambertMichel Ducreux
Mar 28, 2021·Journal of the American College of Surgeons·Ryan M Thomas
Aug 30, 2020·Cytokine & Growth Factor Reviews·Evelyne TassoneJohn Hiscott
Apr 4, 2021·Cancer Discovery·Leire BejaranoJohanna A Joyce

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.